KN 046 Plus Regorafenib in MSS Metastatic Colorectal Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

KN 046 Plus Regorafenib in MSS Metastatic Colorectal Cancer — Stella

Recruiting

Back to Colorectal Cancer trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

China

Beijing Cancer Hospital, Beijing

Key details

Phase

Safety & dosing

Sponsor

Peking University Cancer Hospital & Institute

Enrollment target

~98 participants

Started

October 2023

Primary completion

December 2026

Age range

18 Years and older

Last updated October 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov